Pfizer engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives.... Show more
Segments: Biopharma; Upjohn; Consumer Healthcare
Rating: Strong Buy
Symbol: PFE
Exchange: NYSE
Sector: Healthcare

Pfizer Financial Health

Profitability:8.56/10

Pfizer has better Profitability than 75% of the companies on the Drug Manufacturers industry

Net Margin: 31.17%

Pfizer has better Net Margin than 83.33% of the companies on the Drug Manufacturers industry


ROE (Return on Equity): 6.25%

Pfizer has better ROE (Return on Equity) than 77.78% of the companies on the Drug Manufacturers industry


ROA (Return on Assets): 2.39%

Pfizer has better ROA (Return on Assets) than 58.33% of the companies on the Drug Manufacturers industry


Operating Efficiency:9.97/10

Pfizer has better Operating Efficiency than 91.67% of the companies on the Drug Manufacturers industry

Operating Margin: 136.78%

Pfizer has better Operating Margin than 91.67% of the companies on the Drug Manufacturers industry


Liquidity:2.6/10

Pfizer has worst Liquidity than 83.33% of the companies on the Drug Manufacturers industry

Quick Ratio: 0.78

Pfizer has worst Quick Ratio than 75% of the companies on the Drug Manufacturers industry


Operating Cash Flow Ratio: 0.32

Pfizer has worst Operating Cash Flow Ratio than 75% of the companies on the Drug Manufacturers industry


Solvency:6.25/10

Pfizer has better Solvency than 58.33% of the companies on the Drug Manufacturers industry

Debt to Equity Ratio: 0.8

Pfizer has worst Debt to Equity Ratio than 58.33% of the companies on the Drug Manufacturers industry


Interest Coverage Ratio: 0.32

Pfizer has worst Interest Coverage Ratio than 75% of the companies on the Drug Manufacturers industry


Pfizer revenue by location
Pfizer revenue by segment
Pfizer revenue quarter by quarter
Pfizer operating expenses

👀 Get a summary of every week for free

Top company news, earnings report, analysis and more.

InspectCompany.com

We aim to help investors learn more about the companies in which they invest. We believe investing should be less about trying to find patterns in charts and more about investing in the companies that better represent your vision for the future.

Disclaimer: InspectCompany does not guarantee that any of the information available on our website, APIs or provided by any other means is complete, accurate, current, reliable or appropriate for your needs. Some of our information is provided by third party services and we cannot guarantee that is complete, accurate, current, reliable or appropriate for your needs. The information and recommendations on this site are for educational purposes only and should not be used to replace the advice of financial advisors and other professionals. All our services, information, data and/or recommendations are provided on an "as is" basis and without warranties of any kind, either express or implied. We do not guarantee that our services, information, data and/or recommendations are complete, accurate, current, reliable or appropriate for your needs.  Read more